Gilead HPI licensing adds $35M now + $330M milestones; Phase 2 starts by 2026; strong cash runway. Click for this ASMB update ...

FIB-4 index shows limited accuracy for individual MASLD patients. Learn more about its role and challenges in liver fibrosis screening.

During the holy month of Ramadan, a viral video warns of hidden fungi and contamination risks in dates, but what does scientific research actually say?

Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...

Is your liver health in danger? Scroll down to know what liver damage feels and looks like and what signs the body sends when it is in complete danger.

This study investigates the association between liver fibrosis and diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes mellitus ...

Non-alcoholic fatty liver disease is on the rise and mainly stems from metabolic dysfunction. Dr Sood shares five facts about ...

Kerala researchers study 386 products, covering Ayurveda, Homoeopathy, Siddha, Unani, other traditional remedies. Findings ...

Imaging suggests HCC, yet cirrhosis is uncertain—see why biopsy matters and how AFP, spread, and liver function shape treatment. For oncology clinicians, the Liver Imaging-Reporting and Data System ...

Altimmune (NASDAQ:ALT) executives highlighted clinical progress across multiple pemvidutide programs and discussed the ...

Altimmune (NASDAQ:ALT) executives highlighted recent clinical and regulatory milestones for pemvidutide and outlined plans to ...

Non-alcoholic fatty liver disease (NAFLD) impacts millions globally, often advancing silently while elevating the challenge of metabolic disorders. While medications can aid in controlling some health ...